RIL bets big on health

RIL ’s subsidiary Reliance Life Sciences is all set to start a state-of-the-art biotech sub-city and a medi sub-city in Haryana.

The medi sub-city will come up on 500 hectares of land, and the biotech sub-city on 600 hectares. Both will be a part of Mukesh Ambani’s SEZ in the state.

The two centres will provide “first world treatment at economic rates”, and will specialise in cardiac care, joint replacement and eye treatment.

Reliance will also provide high-tech infrastructure and labs for pharma majors, especially companies which have an export focus.